Dexmedetomidine As an Effective Drug in Reducing Anesthetic Requirements in Patients Undergoing External Dacrocystorhinostomy, a Randomized Controlled Study
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 24
- 试验地点
- 1
- 主要终点
- Maintained hemodynamic values while reducing the anesthetic requirements
研究概览
简要总结
Assessing the intra and postoperative hemodynamic stability in patients undergoing external dacrocystorhinostomy under general anesthesia using Dexmedetomidine as a preoperative sedation compared to traditional technique with intraoperative analgesia and assessing decreased anesthetic requirements intra and postoperative
详细描述
Dexmedetomidine is a highly selective alpha 2 adrenoceptor agonist, having characteristics of natural sleep like sedation, can reduce pain intensity and opioid consumption without influencing the time of recovery from general anesthesia
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 16 Years 至 75 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients of both sexes 16 years to 75 years of age ASA (American society of Anesthesiologists) I-III
排除标准
- •Pediatric age group
- •ASA more than III
研究组 & 干预措施
Dexmedetomidine
Dexmedetomidine 0.25 microgram per kilogram is used in Dacrocystorhinostomy patients 20 minutes before induction of general anesthesia
干预措施: Dexmedetomidine Hydrochloride (Drug)
结局指标
主要结局
Maintained hemodynamic values while reducing the anesthetic requirements
时间窗: from 20 minutes after administering the drug till 2 hours after full recovery
Measuring the heart rate and the blod pressure every 5 minutes intraoperative and for half an hour postoperative to assess hemodynamic stability
次要结局
- Delerium(from 20 minutes after administering the drug till 2 hours after full recovery)
研究者
Dina Moustafa Mohamed
Principal investigator
Research Institute of Ophthalmology, Egypt